 |
|
| Sample Newsletters | MarketPlace AIS Products & Services |
|
In their pursuit of more efficient health care services and coverage, many health plans, PBMs and SPPs have begun bringing comparative effectiveness research (CER) and cost data into the equation. With the availability of federally funded CER data still some time away, many plans, PBMs and SPPs are already taking different paths to access and apply this information. Hear leading payer industry experts assess different strategies health plans, PBMs and SPPs are pursuing to generate and utilize their own CER and cost data and/or obtain them from external sources. You’ll get insider perspectives on what plans, PBMs and SPPs are doing now and changes they expect in the next two years on questions such as:
GARY OWENS, M.D., is the president of Gary Owens Associates, a consulting firm for health plans, employee benefit management firms and pharmaceutical and biotech companies. Before that, he was vice president for medical management at Independence Blue Cross (IBC), Pennsylvania’s leading health plan, with more than 2 million members. In that role, he managed pharmacy operations for more than 2 million members. Dr. Owens has expertise in the evaluation of new technology, medical management programs and strategy, health plan operations, benefit design, formulary development and drug management. He has managed medical review services, including precertification of medical procedures, hospital care level reviews, high-tech radiology precertification, discharge planning activities and case management. Dr. Owens was responsible for evaluation of new drugs and new technologies as manager of the technology evaluation unit, a department that he founded in 1993 at the Pennsylvania payer. While at IBC, he headed the team that developed an injectable management strategy, which included a program to assess and manage biotech and bio-oncology products. SARAH COLLINS is president of PharManage, LLC, a consulting group of senior industry executives specializing in reimbursement services, including strategy development and market assessment, for pharmaceutical and biotechnology clients. She has an extensive background within the pharmaceutical and biotechnology industries. She has worked in research and consulting for Apical Research Team, PAREXEL and Abt Associates. For the last decade, Ms. Collins’ work has focused on public and private payers, including managed care organizations, CMS, PBMs, the Department of Defense and the Department of Veterans Affairs. Her reimbursement work has included oral agents, physician- and self-administered agents and alternative delivery mechanisms, such as transdermal patches and sprays. She has led projects in numerous therapeutic categories, including oncology, cardiovascular disease, HIV/AIDS, rheumatoid arthritis, osteoarthritis, allergies/asthma, women’s health, insomnia, diagnostics, ophthalmology and others. STEVE MILLER, M.D., is senior vice president and chief medical officer in research and clinical sciences for Express Scripts, Inc. He joined Express Scripts in 2005 and has years of experience as a medical researcher, clinician and administrator. Dr. Miller has been actively involved in the development of Express Scripts’ clinical programs supporting the use of generic pharmaceuticals and specialty medications. He is a leader in the promotion of legislation to create a pathway at the FDA for regulation of biogenerics and biosimilars. He previously served as vice president and chief medical officer at Barnes-Jewish Hospital/Washington University School of Medicine in St. Louis, where he had responsibility for oncology services, radiation oncology and patient safety and quality, among other areas. Dr. Miller earned his medical degree from the University of Missouri-Kansas City and received additional training in the Pathology and Research fellowship at the University of Alabama at Birmingham and training in cardiology at the University of California, San Francisco. Dr. Miller also earned an MBA at the Olin School of Business at Washington University in St. Louis. He has published more than 80 scientific articles in the areas of acute and chronic renal failure, transplantation, hypertension and medical economics. Moderator: Angela Maas, managing editor of AIS’s Specialty Pharmacy News.
Pharmacy, clinical services and medical directors; strategic planners; product development, contracting and marketing executives; and financial and operations executives at
Please note that CDs and MP3 files will be available within three weeks of the conference date. Audio CDs (and accompanying written materials) are shipped via UPS. Please give us your street address when you order (UPS does not deliver to PO boxes). You should receive your order within 5-7 business days.* Shipping cost is $5. MP3 files will be delivered as a download link within a PDF file of the accompanying written materials. Shipping will NOT be charged for this item.
Rush Orders: Please call us at 800-521-4323 to place a rush order.* We will overnight your order for an additional charge of $30, or you can give us your FedEx or UPS account number and we will charge the shipping to your account. Rush orders placed after 3:00pm EST will not be shipped out until the next business day. *CDs and MP3 files will be available within three weeks of the conference date.
Listeners will also receive practical written information to supplement information covered by the audioconference speakers.
For further information call 800-521-4323 or e-mail customerserv@aishealth.com |
|||||||||||||||||||||||
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail customerserv@aishealth.com